Please assess the completion status of the following clinical trial:

Trial Title: Testing the Efficacy in Adults With Cold of HEalsea Rescue*

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Male/Female subjects \>18 years~2. Acute infectious rhinitis/rhinosinusitis for ≤48h before trial entry~3. Symptoms of headache, muscle ache, chilliness, sore throat, blocked nose, runny nose, cough, sneezing with a score ≤9 (according to a self-rated symptom score; scale: 0 → 3 \[0: no symptom to 3: severe intensity\])~4. At least one of these symptoms: sore throat, runny nose or blocked nose (i.e., with a score ≥1)~5. Willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the information consent form~6. Patient with a smartphone and an internet connection.~Exclusion Criteria:~1. Known hypersensitivity/allergy to any component of the test device~2. Medical history or any current disease that is considered by the investigator as a reason for non-inclusion~3. Severe nasal septum deviation or other condition that could cause nasal obstruction such as the presence of nasal polyps~4. History of nasal or sinus surgery that in the opinion of the investigator may influence symptom scores~5. Antibiotic intake within 2 weeks before screening~6. Systemic or local corticosteroids (nasal route or inhalation) within 4 weeks before screening~7. Antihistamines intake for allergy when treatment was started from less than 4 weeks~8. Chronic decongestant use~9. Recent (within the previous 2 days) intake of a common cold medicine that in the opinion of the investigator may influence symptom score at screening (NSAID, nasal decongestants, cough medicines)~10. Pregnant/Lactating female or absence of efficient contraception

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Healsea Rescue* group (Type: EXPERIMENTAL): Subjects will receive Healsea Rescue\* according to its intended use.
- Placebo group (Type: PLACEBO_COMPARATOR): Subjects will receive Placebo according to identical posology, instructions for use, contraindication, precaution of use and labelling to those of Healsea Rescue.

Based on this trial design, predict the completion outcome and termination type (if applicable).